α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12944-015-0090-6
Published Online: 2015-08-18
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Mason, Julie K.
Klaire, Sukhpreet
Kharotia, Shikhil
Wiggins, Ashleigh K A
Thompson, Lilian U.